跳至主要内容
临床试验/NCT01705639
NCT01705639已完成3 期

Does Melatonin Treatment Affect Glucose Tolerance Among Individuals With a Variant (rs10830963) of the Melatonin Receptor 1B (MTNR1B) Gene?

University of Helsinki2 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2012年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
45
试验地点
2
主要终点
Glucose tolerance

研究概览

简要总结

The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3 months:

  • OGTT
  • questionnaires about sleep and activity
  • Actigraph
  • Anthropometry
  • Blood pressure

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed informed concent
  • Known genotype for MTNR1B from the Botnia-ppp study
  • Age 18-75 years

排除标准

  • Positive GAD-ab
  • Sever dysregulated hypertension
  • severe coronary heart disease or arrythmias
  • previous or ongoing severe ventricle or duodenal ulcer
  • psychosis or anxiety disorder
  • regular use of sleep pills, antidepressants or neuroleptics
  • creatinine > 130 µmol/L
  • elevated liver enzymes (ASAT, ALAT, ALP, GT, bilirubin) > 3 times reference value
  • inability to sign informed concent
  • other factor with according to the physician may affect treatment or results.
  • participation in other clinical study
  • allergy to melatonin or other substance in the capsule
  • hereditary galactose intolerance or glucose/galactose malabsorption
  • intention to become pregnant

研究组 & 干预措施

Melatonin

Experimental

melatonin 4mg od for 3 months

干预措施: Melatonin (Drug)

结局指标

主要结局

Glucose tolerance

时间窗: 3 months

Glucose tolerance is measured in OGTT: 0,30,60,90 and 120 minute values of glucose and insulin.

次要结局

  • sleep(3 months)
  • Activity(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tom Forsén

MD PhD

University of Helsinki

研究点 (2)

Loading locations...

相似试验